Life sciences companies are facing tougher obstacles in bringing new therapies to market than ever before. With an average drug approval process taking up to 15 years and billions of dollars to complete, new technological advancements are being leveraged to help manage the growing clinical, regulatory, and commercial needs necessary to accelerate time to market.

Read more

Life science IT departments face increasing demands because of clinical trials’ growing complexities, including the proliferation of specialized applications, ballooning numbers of stakeholders, and data security and privacy considerations.

Read more